COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1208: Articles 12071-12080  | Next

Viral replication in human macrophages enhances an inflammatory cascade and interferon driven chronic COVID-19 in humanized mice.
Sefik, E., Qu, R., Kaffe, E., Zhao, J., Junqueira, C., Mirza, H., Brewer, R., Han, A., Steach, H., Israelow, B., Chen, Y. G., Halene, S., Iwasaki, A., Meffre, E., Nussenzweig, M., Lieberman, J., Wilen, C. B., Kluger, Y., Flavell, R. A.
10.1101/2021.09.27.461948 — Posted: 2021-09-27
COVID-19 L·OVE repository is highly comprehensive and can be used as a single source for COVID-19 studies
Verdugo-Paiva, F., Vergara, C., Avila, C., Castro, J., Cid Cid, J., Contreras, V., Jara, I., Jimenez, V., Lee, M. H., Munoz, M., Rojas Gomez, A. M., Roson-Rodriguez, P., Serrano-Arevalo, K., Silva-Ruz, I., Vasquez-Laval, J., Zambrano-Achig, P., Zavadzki, G., Rada, G.
10.1101/2021.09.21.21263849 — Posted: 2021-09-27
Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2 infected Pakistani Patients
Omer, S., Sarwar, M. B., Roman, M., Usman, M., Khan, M. A., Afzal, N., Qaiser, T. A., Yasir, M., Shahzad, F., Tahir, R., Ayub, S., Akram, J., Jahan, S.
10.1101/2021.09.25.21264111 — Posted: 2021-09-27
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
Baker, D., MacDougall, A., Kang, A. S., Schmierer, K., Giovannoni, G., Dobson, R.
10.1101/2021.09.26.21264023 — Posted: 2021-09-27
Non-invasive Vagus Nerve Stimulation for Respiratory Symptoms of COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)
Tornero, C., Pastor, E., Garzando, M. d. M., Orduna, J., Forner, M. J., Bocigas, I., Cedeno, D., Vallejo, R., Staats, P., Liebler, E.
10.1101/2021.09.24.21264045 — Posted: 2021-09-27 Discussion: Offsite
Multi-omics approach identifies novel age-, time- and treatment-related immunopathological signatures in MIS-C and pediatric COVID-19
Sacco, K., Castagnoli, R., Vakkilainen, S., Liu, C., Delmonte, O. M., Oguz, C., Kaplan, I. M., Alehashemi, S., Burbelo, P. D., Bhuyan, F., de Jesus, A. A., Dobbs, K., Rosen, L. B., Cheng, A., Shaw, E., Vakkilainen, M. S., Pala, F., Lack, J., Zhang, Y., Fink, D., Oikonomou, V., Snow, A. L., Dalgard, C. L., Chen, J., Sellers, B. A., Montealegre Sanchez, G. A., Barron, K., Rey, E., Vial, M. C., Poli, M. C., Licari, A., Montagna, D., Marseglia, G. L., Licciardi, F., Ramenghi, U., Discepolo, V., Lo Vecchio, A., Guarino, A., Eisenstein, E. M., Imberti, L., Sottini, A., Biondi, A., Mato, S., Gerstbacher, D., Truong, M., Stack, M. A., Magliocco, M., Bosticardo, M., Kawai, T., Danielson, J. J., Hulett, T., Askenazi, M., NIAID Immune Response to COVID Group, , Chile MIS-C Group, , Pavia Pediatric COVID-19 Group, , Cohen, J. I., Su, H. C., Kuhns, D. B., Lionakis, M. S., Snyder, T. M., Holland, S. M., Goldbach-Mansky, R., Tsang, J. S., Notarangelo, L. D.
10.1101/2021.09.24.21263853 — Posted: 2021-09-27
Acquired peripheral nerve injuries associated with severe COVID-19
Franz, C. K., Murthy, N. K., Malik, G. R., Kwak, J. W., D'Andrea, D., Wolfe, A. R., Farr, E., Stearns, M. A., Deshmukh, S., Tavee, J. O., Sun, F., Swong, K. N., Rydberg, L., Cotton, R. J., Wolfe, L. F., Walter, J. M., Coleman, J. M., Rogers, J. A.
10.1101/2021.09.24.21263996 — Posted: 2021-09-27
The kinetic of SARS-CoV-2 antibody (Ab) decline determines the threshold for Ab persistence up to one year
Garner-Spitzer, E., Wagner, A., Kundi, M., Stockinger, H., Repic, A., Schoetta, A.-M., Gudipati, V., Huppa, J. B., Kunert, R., Mayrhofer, P., Kreil, T. R., Farcet, M. R., Hoeltl, E., Wiedermann, U.
10.1101/2021.09.20.21263172 — Posted: 2021-09-27
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint
Chen, X., Wang, W., Chen, X., Wu, Q., Sun, R., Ge, S., Zheng, N., Lu, W., Yang, J., Rodewald, L., Yu, H.
10.1101/2021.09.23.21263715 — Posted: 2021-09-27
Diagnostic Yield of Screening for SARS-CoV-2 among Patients Admitted for Alternate Diagnoses
Davis, P., Rosychuk, R. J., Hau, J. P., Cheng, I., McRae, A. D., Daoust, R., Lang, E., Turner, J., Khangura, J., Fok, P. T., Stachura, M., Brar, B., Hohl, C. M.
10.1101/2021.09.23.21264036 — Posted: 2021-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).